We support innovative biotechs in Italy as they push promising research programs in rare genetic disorders towards preclinical and clinical development.
Our unique collaboration with the Telethon Foundation aims to bring Italian scientific excellence to the world stage. Our mission is to foster a thriving biotech ecosystem in Italy.
|2018||Sofinnova Telethon Fund||€108 million|
Fund: Sofinnova Telethon Fund
AMT: €108 million
“We come from the tech transfer world so we understand what it takes to build companies around the expertise at universities and institutions."
“There has to be more willingness to invest in the early stage. If nobody had invested in mRNA technology 10 years ago, I don't think we would have had the Covid vaccine in less than one year.”
Nephris welcomes discovery of novel pathogenic factor in diabetic kidney disease
Genespire appoints Dr. Sabah Sallah as Chief Medical Officer
AAVantgarde announces the appointment of Naveed Shams, M.D., Ph.D. as Chief Development and Medical Officer
Sofinnova Partners Announces New Investment In Nanophoria, Developer Of An Innovative Non-viral Drug Delivery Platform
Sofinnova Partners announces new investment in Nephris, an innovative biotech targeting chronic kidney diseases